Unomr is a deep-tech startup from ETH that is developing a patented analytical instrument to revolutionize medical research. By measuring single proteins with unattainable accuracy and sensitivity, we give academic research as well as biotech and pharmaceutical companies new tools to study the effects of pharmaceutical products. With our serial interface nanopore technology, our customers can develop treatments for diseases that are currently incurable faster and more efficiently. Currently we focus on the measurement of site-specific protein glycosylation. Our vision is to enable the analysis of rare proteins such as cancer biomarkers and de-novo protein sequencing with our team of experts who have years of experience in the development of biosensors.

STARTUP PITCH SESSION CONTINUED

Information

Log in